GFO Issue 135, Article Number: 3
Sub-title :
ABSTRACT
ABSTRACT
Details are provided of the Board's decision regarding each eligible Round 10 proposal.
Based on advice from the TRP, the Board divided eligible Round 10 proposals into five categories, as follows:
- Category 1: Approved proposals requiring no or minor clarifications; any clarifications need to be provided within eight weeks and then given a final approval by the TRP Chair or Vice-Chair.
- Category 2: Proposals that are approved subject to the required clarifications being provided within a limited timeframe (six weeks for the applicant to provide an initial detailed response to the TRP queries, and a further three months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
- Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
- Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in a future round following major revision.
- Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
The Board approved all proposals in Categories 1, 2 and 2B.
Table 8 provides a summary of the Round 10 results by category. Tables 9 and 10 show the results for each applicant.
Table 8: Round 10 results by category
Category
Number of proposals
TRP-recommended funding
(Years 1-2)
(Years 1-5)
Approved: Category 1
3
$0.05 b.
$0.14 b.
Approved: Category 2
49
$1.03 b.
$2.73 b.
Approved: Category 2B
27
$0.65 b.
$1.85 b.
Subtotal: All Approved Proposals:
79
$1.73 b.
$4.72 b.
Not Approved: Category 3
56
$1.64 b.
$4.21 b.
Not Approved: Category 4
15
$0.78 b.
$2.22 b.
Not Approved: Parts of Category 1, 2 and 2B proposals not recommended for funding *
n/a
$0.14 b.
$0.48 b.
Subtotal: All Non-Approved Proposals:
71
$2.56 b.
$6.91 b.
Total: All Proposals
150
$4.30 b.
$11.63 b.
* This refers to a situation where a disease proposal with an HSS request attached has been submitted, and the TRP has recommended, and the Board has approved, either the disease proposal or the HSS request, but not both.
Table 9: Round 10 results, by country
Notes:
1. In the following table, DP = disease part.
2. For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.
Applicant
Disease component
Applicant type
Decision
Cate-gory
Cost
(Years 1-2)
(Years 1-5)
Afghanistan
TB (DP + HSS part)
CCM
Approved
2
€ 16,132,533
€ 23,330,719
Angola
HIV
CCM
Approved
2B
$25,877,952
$68,884,971
Angola
Malaria
CCM
Approved
1
$40,435,549
$111,239,055
Argentina
HIV MARPs
CCM
Approved
2
$4,933,812
$12,500,000
Armenia
HIV MARPs
CCM
Not approved
3
€ 2,328,230
€ 4,817,816
Armenia *
TB (DP)
CCM
Approved
2
€ 3,310,881
€ 8,881,651
Armenia
TB (HSS part)
CCM
Not approved
n/a
€ 1,180,614
€ 2,159,904
Azerbaijan
HIV MARPs
CCM
Not approved
3
$3,546,724
$12,466,986
Azerbaijan
Malaria
CCM
Not approved
3
€ 1,880,538
€ 3,571,100
Bangladesh **
TB
CCM
Approved
2B
$11,677,496
$98,543,757
Belize
HIV MARPs
CCM
Not approved
3
$2,602,746
$6,722,026
Belize
TB
CCM
Not approved
4
$2,823,065
$5,960,681
Benin
HIV
CCM
Not approved
3
€ 11,286,254
€ 21,692,352
Benin
TB
CCM
Not approved
3
€ 993,858
€ 2,274,009
Bosnia & Herz.
HIV
CCM
Not approved
4
€ 2,800,310
€ 5,497,810
Botswana
HIV
CCM
Not approved
3
$47,926,893
$137,642,491
Botswana
TB
CCM
Not approved
3
$10,828,604
$25,258,210
Brazil
HIV MARPs
CCM
Not approved
3
$5,000,000
$12,500,000
Burkina Faso
HIV (DP)
CCM
Approved
2B
€ 38,993,903
€ 97,448,392
Burkina Faso
HIV (HSS part)
CCM
Not approved
n/a
€ 10,272,650
€ 24,384,963
Burundi
TB
CCM
Not approved
3
$4,830,351
$13,212,893
Cambodia
HIV
CCM
Not approved
3
$23,124,597
$47,452,279
Cambodia
TB (DP + HSS part)
CCM
Not approved
3
$47,313,760
$132,570,309
Cameroon
HIV
CCM
Approved
2B
€ 30,200,540
€ 97,411,942
Cape Verde
Malaria
CCM
Approved
2B
€ 968,724
€ 1,414,366
Central Af. Rep.
HIV (DP + HSS part)
CCM
Not approved
3
€ 29,077,778
€ 64,570,395
Chad
HIV
CCM
Not approved
3
€ 31,801,787
€ 94,985,597
Chad
TB (DP + HSS part)
CCM
Not approved
3
€ 11,599,749
€ 22,450,241
China
Malaria
CCM
Approved
2B
$5,830,102
$15,704,363
Colombia
TB
CCM
Approved
2B
$5,390,584
$11,271,656
Congo Rep.
HIV
CCM
Not approved
3
€ 4,674,974
€ 9,978,943
Congo DR
HIV
CCM
Not approved
3
$111,533,674
$295,297,357
Congo DR
Malaria
CCM
Approved
2
$73,922,870
$185,122,386
Cote d'Ivoire
HIV (DP + HSS part)
CCM
Not approved
3
€ 57,632,004
€ 133,432,755
Djibouti
TB
CCM
Approved
2
€ 2,461,552
€ 6,080,117
Dominican Rep.
HIV MARPs
CCM
Not approved
4
$4,950,940
$12,496,996
Eritrea *
HIV (DP + HSS part)
CCM
Approved
2
$20,818,140
$59,897,311
Eritrea * **
TB
CCM
Approved
2B
$7,316,801
$22,815,431
Ethiopia
HIV
CCM
Not approved
3
$88,149,150
$176,458,326
Ethiopia
Malaria (DP + HSS part)
CCM
Not approved
3
$97,848,890
$245,989,480
Ethiopia
TB
CCM
Not approved
3
$21,107,334
$82,169,387
Georgia
HIV MARPs
CCM
Approved
2
€ 3,105,210
€ 8,860,077
Georgia
TB
CCM
Approved
2
€ 7,695,603
€ 21,727,729
Ghana
HIV (DP + HSS part)
CCM
Not approved
4
$499,428,723
$1,420,138,447
Ghana *
TB
CCM
Approved
2B
$31,897,744
$77,418,445
Guinea
HIV (DP + HSS part)
CCM
Approved
2B
$20,877,516
$56,875,437
Guinea
Malaria
CCM
Approved
2B
$32,046,938
$46,625,648
Guinea Bissau
HIV (DP + HSS part)
CCM
Not approved
3
€ 26,167,631
€ 63,815,647
Guyana
TB
CCM
Not approved
4
$486,607
$1,050,801
Honduras
TB
CCM
Approved
2B
$6,030,951
$12,402,425
India
HIV
CCM
Not approved
3
$21,412,956
$61,404,090
Indonesia
TB (DP + HSS part)
CCM
Approved
2
$47,727,271
$157,544,680
Iran
Malaria
CCM
Approved
2
$9,363,548
$19,578,464
Jordan
TB
CCM
Approved
2
$2,078,829
$4,666,284
Kazakhstan
HIV MARPs
CCM
Approved
2
$2,404,755
$12,449,062
Kenya
HIV
CCM
Approved
2B
$93,376,285
$345,103,871
Kenya
Malaria
CCM
Approved
2
$49,979,579
$138,370,324
Kyrgyz Rep.
HIV
CCM
Approved
2
$11,207,840
$41,480,486
Kyrgyz Rep.
TB
CCM
Not approved
3
$3,842,777
$5,659,777
Lao PDR
TB (HSS part)
CCM
Not approved
n/a
$8,155,754
$17,158,018
Lao PDR **
TB (DP)
CCM
Approved
2
$3,255,999
$12,887,910
Lesotho
HIV
CCM
Not approved
3
$29,594,699
$65,273,286
Liberia
Malaria (DP + HSS part)
CCM
Approved
2
$28,698,063
$68,892,692
Liberia
TB
CCM
Approved
2B
$2,862,226
$16,061,899
Macedonia
HIV MARPs
CCM
Approved
1
€ 2,825,259
€ 9,407,934
Macedonia
TB
CCM
Approved
2
€ 2,901,528
€ 6,112,713
Madagascar
HIV (DP + HSS part)
CCM
Not approved
3
$46,050,649
$110,739,971
Malawi
HIV
CCM
Not approved
3
$164,254,176
$561,450,164
Malaysia
HIV MARPs
CCM
Approved
2B
$4,672,630
$12,405,288
Maldives
HIV MARPs
CCM
Not approved
3
$2,880,814
$8,044,746
Mali
Malaria
CCM
Approved
2B
€ 24,827,735
€ 94,873,243
Mali
TB
CCM
Approved
2
€ 8,053,957
€ 13,773,341
Mauritius
HIV MARPs
CCM
Not approved
3
$2,870,148
$12,435,364
Moldova
HIV MARPs
CCM
Not approved
3
$3,849,298
$12,491,713
Mongolia
HIV
CCM
Not approved
4
$2,218,185
$7,248,739
Mongolia **
TB (DP + HSS part)
CCM
Approved
2
$3,696,354
$9,052,049
Morocco
HIV
CCM
Approved
2
$14,672,516
$43,597,649
Morocco
TB
CCM
Approved
2
$5,014,439
$10,795,334
Mozambique
HIV
CCM
Not approved
3
$54,163,105
$131,214,912
Mozambique
TB
CCM
Not approved
3
$25,407,092
$69,822,783
Namibia
HIV
CCM
Not approved
4
$15,248,614
$44,292,453
Namibia
TB
CCM
Approved
2
$12,524,672
$32,994,241
Nepal
HIV
CCM
Approved
2
$16,150,553
$57,273,249
Nicaragua
TB
CCM
Not approved
3
$4,106,578
$8,247,665
Niger
HIV
CCM
Not approved
3
€ 30,335,989
€ 73,945,907
Niger
Malaria
CCM
Not approved
3
€ 72,627,052
€ 130,641,962
Niger
TB (DP + HSS part)
CCM
Approved
2B
€ 19,035,383
€ 42,226,096
Nigeria
HIV (DP + HSS part)
CCM
Not approved
4
$97,491,288
$383,708,645
Pakistan *
Malaria (DP)
CCM
Approved
2B
$23,395,667
$51,516,709
Pakistan
Malaria (HSS part)
CCM
Not approved
n/a
$15,199,740
$21,594,900
Panama
HIV MARPs
CCM
Approved
2
$4,202,744
$10,273,513
Papua NG *
HIV (DP + HSS part)
CCM
Approved
2
$23,419,727
$46,697,052
Peru
HIV MARPs
CCM
Approved
2
$4,999,999
$12,499,997
Peru
Malaria
CCM
Not approved
3
$2,835,863
$7,741,937
Peru
TB
CCM
Not approved
3
$15,481,203
$29,837,075
Russian Fed.
TB
CCM
Approved
2B
$63,472,958
$126,926,245
Russian Fed.
TB
Sub-CCM
Not approved
4
€ 20,170,145
€ 36,360,264
Sao Tome & P.
HIV
CCM
Approved
2
$1,279,852
$2,476,713
Senegal
Malaria
CCM
Approved
2
€ 21,650,781
€ 62,865,723
Senegal * **
TB
CCM
Approved
2
€ 6,335,035
€ 17,460,725
Sierra Leone
Malaria
CCM
Approved
2
$23,255,609
$62,649,856
Sierra Leone
TB (DP + HSS part)
CCM
Not approved
3
$34,333,373
$77,234,629
Somalia
Malaria (DP + HSS part)
Non-CCM
Approved
2
$39,333,002
$84,550,325
Somalia * **
TB
Non-CCM
Approved
2B
$14,213,393
$58,380,928
South Africa
HIV
CCM
Approved
2
$128,481,275
$302,717,719
Sri Lanka
TB (DP + HSS part)
CCM
Not approved
3
$11,845,852
$25,088,859
Sudan North
HIV
CCM
Approved
2
$21,944,538
$61,919,606
Sudan North
Malaria
CCM
Approved
2B
$61,256,082
$182,841,841
Sudan South
HIV
Sub-CCM
Not approved
4
$65,528,320
$135,697,425
Sudan South
Malaria
Sub-CCM
Approved
2
$26,486,653
$98,618,453
Sudan South
TB
Sub-CCM
Not approved
3
$16,374,061
$50,114,047
Swaziland
HIV
CCM
Not approved
3
$34,723,593
$89,609,304
Swaziland **
TB
CCM
Approved
2
$11,202,195
$39,004,228
Syria *
HIV MARPs
CCM
Approved
2B
$1,723,169
$3,396,722
Tajikistan
HIV
CCM
Not approved
3
$20,521,257
$64,745,498
Tajikistan
TB
CCM
Not approved
3
$49,913,253
$115,418,678
Tanzania
HIV
CCM
Not approved
3
$50,880,157
$113,178,230
Tanzania
TB
CCM
Not approved
3
$33,201,781
$68,786,103
Thailand
HIV
CCM
Approved
2
$15,398,249
$42,088,572
Thailand *
Malaria
CCM
Approved
2B
$32,500,432
$78,378,690
Thailand
TB
CCM
Approved
2
$12,344,773
$31,716,829
Timor-Leste
HIV
CCM
Approved
1
$6,798,682
$14,254,688
Timor-Leste *
Malaria
CCM
Approved
2B
$7,170,680
$22,349,915
Timor-Leste
TB
CCM
Not approved
3
$2,706,769
$9,661,901
Togo
HIV
CCM
Not approved
3
€ 6,280,885
€ 16,083,684
Tunisia
HIV MARPs
CCM
Not approved
3
$4,144,950
$12,499,365
Uganda
HIV (DP)
CCM
Not approved
n/a
$55,834,292
$217,300,859
Uganda
HIV (HSS part)
CCM
Approved
2
$17,917,965
$25,251,193
Uganda
Malaria
CCM
Approved
2
$53,167,057
$155,963,673
Uganda
TB
CCM
Approved
2
$10,391,585
$24,757,129
Ukraine
HIV
CCM
Approved
2
$95,842,099
$305,535,421
Uruguay
HIV MARPs
CCM
Approved
2
$3,953,375
$9,572,417
Uzbekistan
HIV
CCM
Approved
2
$9,519,645
$14,828,347
Vietnam
HIV (DP)
CCM
Not approved
n/a
$45,071,739
$188,864,423
Vietnam
HIV (HSS part)
CCM
Approved
2B
$42,102,165
$86,636,150
Yemen
HIV (DP + HSS part)
CCM
Not approved
3
$14,565,766
$32,312,943
Zambia *
HIV
CCM
Approved
2
$102,851,986
$259,216,608
Zanzibar (Tanz.)
TB
CCM
Approved
2
$2,633,434
$5,912,925
Zimbabwe
HIV (DP + HSS part)
CCM
Not approved
3
$118,402,303
$342,054,472
Zimbabwe
Malaria
CCM
Approved
2
$14,550,666
$24,960,569
Zimbabwe
TB
CCM
Not approved
3
$12,193,205
$25,507,117
Total – 135 country-based proposals
* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal.
** These are consolidated proposals. The TRP-recommended funding has been reduced to remove amounts included in the proposals for existing, already funded programmes.
Table 10: Round 10 results for regional applicants
Note: For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.
Applicant
Disease component
Applicant type
Decision
Cate-gory
Cost
Years 1-2
Years 1-5
AMREF (Re Burundi, Ethiopia, Kenya, Tanzania, Uganda)
TB
RO
Not approved
4
$29,868,200
$63,996,437
APN+ (Re Bangladesh, Indonesia, Lao PDR, Nepal, Pakistan, Philippines, Viet Nam) *
HIV
RO
Approved
2
$1,200,000
$3,000,000
ASICAL (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay)
HIV MARPs
RO
Not approved
3
$4,827,281
$11,149,346
CONGA (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama)
HIV MARPs
RO
Not approved
4
$4,506,212
$12,451,594
ECSA (Re Zambia, Zimbabwe)
TB
RO
Not approved
3
$3,322,054
$14,593,861
GLIA (Re Burundi, Congo DR, Kenya, Rwanda, Tanzania, Uganda)
HIV MARPs
RO
Not approved
4
$4,873,647
$12,499,735
HIVOS-SA (Re Lesotho, Mauritius, Namibia, South Africa, Swaziland)
HIV
RO
Not approved
4
$12,130,614
$36,066,771
ISEAN-HIVOS (Re Indonesia, Malaysia, Philippines, Timor-Leste)
HIV MARPs
RO
Approved
2B
$4,767,802
$12,473,395
MENAHRA (Re Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, West Bank and Gaza, Pakistan, Syria, Tunisia) *
HIV MARPs
RO
Approved
2B
$3,209,492
$8,352,698
Meso (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama)
HIV
RCM
Not approved
3
$7,868,536
$23,214,775
MOZIZA (Re Mozambique, South Africa, Zimbabwe)
Malaria
RCM
Not approved
4
$12,322,727
$28,043,158
OECS (Re Antigua and Barbuda, Dominica, Grenada, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and Grenadines)
HIV
RCM
Not approved
3
$3,112,877
$9,059,745
REDCA+ (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama) **
HIV
RO
Approved
2
$2,366,057
$9,229,855
REDLACTRANS (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay)
HIV MARPs
RO
Not approved
3
$4,994,209
$12,500,000
REDTRASEX (Re Argentina, Bolivia, Brazil, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay)
HIV MARPs
RO
Approved
2
$4,328,974
$12,496,279
Total – 15 regional proposals
RO = Regional organisation RCM = Regional coordinating mechanism
* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal.
** This is a consolidated proposal. The TRP-recommended funding has been reduced to remove amounts included in the proposal for existing, already funded programmes.
- Category 1: Approved proposals requiring no or minor clarifications; any clarifications need to be provided within eight weeks and then given a final approval by the TRP Chair or Vice-Chair.
- Category 2: Proposals that are approved subject to the required clarifications being provided within a limited timeframe (six weeks for the applicant to provide an initial detailed response to the TRP queries, and a further three months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
- Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
- Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in a future round following major revision.
- Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
Table 8: Round 10 results by category
|
Category |
Number of proposals |
TRP-recommended funding |
|
|
(Years 1-2) |
(Years 1-5) |
||
| Approved: Category 1 |
3 |
$0.05 b. |
$0.14 b. |
| Approved: Category 2 |
49 |
$1.03 b. |
$2.73 b. |
| Approved: Category 2B |
27 |
$0.65 b. |
$1.85 b. |
| Subtotal: All Approved Proposals: |
79 |
$1.73 b. |
$4.72 b. |
| Not Approved: Category 3 |
56 |
$1.64 b. |
$4.21 b. |
| Not Approved: Category 4 |
15 |
$0.78 b. |
$2.22 b. |
| Not Approved: Parts of Category 1, 2 and 2B proposals not recommended for funding * |
n/a |
$0.14 b. |
$0.48 b. |
| Subtotal: All Non-Approved Proposals: |
71 |
$2.56 b. |
$6.91 b. |
| Total: All Proposals |
150 |
$4.30 b. |
$11.63 b. |
Table 9: Round 10 results, by country
Notes: 1. In the following table, DP = disease part. 2. For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.|
Applicant |
Disease component |
Applicant type |
Decision |
Cate-gory |
Cost |
||
|
(Years 1-2) |
(Years 1-5) |
||||||
| Afghanistan | TB (DP + HSS part) |
CCM |
Approved |
2 |
€ 16,132,533 |
€ 23,330,719 |
|
| Angola | HIV |
CCM |
Approved |
2B |
$25,877,952 |
$68,884,971 |
|
| Angola | Malaria |
CCM |
Approved |
1 |
$40,435,549 |
$111,239,055 |
|
| Argentina | HIV MARPs |
CCM |
Approved |
2 |
$4,933,812 |
$12,500,000 |
|
| Armenia | HIV MARPs |
CCM |
Not approved |
3 |
€ 2,328,230 |
€ 4,817,816 |
|
| Armenia * | TB (DP) |
CCM |
Approved |
2 |
€ 3,310,881 |
€ 8,881,651 |
|
| Armenia | TB (HSS part) |
CCM |
Not approved |
n/a |
€ 1,180,614 |
€ 2,159,904 |
|
| Azerbaijan | HIV MARPs |
CCM |
Not approved |
3 |
$3,546,724 |
$12,466,986 |
|
| Azerbaijan | Malaria |
CCM |
Not approved |
3 |
€ 1,880,538 |
€ 3,571,100 |
|
| Bangladesh ** | TB |
CCM |
Approved |
2B |
$11,677,496 |
$98,543,757 |
|
| Belize | HIV MARPs |
CCM |
Not approved |
3 |
$2,602,746 |
$6,722,026 |
|
| Belize | TB |
CCM |
Not approved |
4 |
$2,823,065 |
$5,960,681 |
|
| Benin | HIV |
CCM |
Not approved |
3 |
€ 11,286,254 |
€ 21,692,352 |
|
| Benin | TB |
CCM |
Not approved |
3 |
€ 993,858 |
€ 2,274,009 |
|
| Bosnia & Herz. | HIV |
CCM |
Not approved |
4 |
€ 2,800,310 |
€ 5,497,810 |
|
| Botswana | HIV |
CCM |
Not approved |
3 |
$47,926,893 |
$137,642,491 |
|
| Botswana | TB |
CCM |
Not approved |
3 |
$10,828,604 |
$25,258,210 |
|
| Brazil | HIV MARPs |
CCM |
Not approved |
3 |
$5,000,000 |
$12,500,000 |
|
| Burkina Faso | HIV (DP) |
CCM |
Approved |
2B |
€ 38,993,903 |
€ 97,448,392 |
|
| Burkina Faso | HIV (HSS part) |
CCM |
Not approved |
n/a |
€ 10,272,650 |
€ 24,384,963 |
|
| Burundi | TB |
CCM |
Not approved |
3 |
$4,830,351 |
$13,212,893 |
|
| Cambodia | HIV |
CCM |
Not approved |
3 |
$23,124,597 |
$47,452,279 |
|
| Cambodia | TB (DP + HSS part) |
CCM |
Not approved |
3 |
$47,313,760 |
$132,570,309 |
|
| Cameroon | HIV |
CCM |
Approved |
2B |
€ 30,200,540 |
€ 97,411,942 |
|
| Cape Verde | Malaria |
CCM |
Approved |
2B |
€ 968,724 |
€ 1,414,366 |
|
| Central Af. Rep. | HIV (DP + HSS part) |
CCM |
Not approved |
3 |
€ 29,077,778 |
€ 64,570,395 |
|
| Chad | HIV |
CCM |
Not approved |
3 |
€ 31,801,787 |
€ 94,985,597 |
|
| Chad | TB (DP + HSS part) |
CCM |
Not approved |
3 |
€ 11,599,749 |
€ 22,450,241 |
|
| China | Malaria |
CCM |
Approved |
2B |
$5,830,102 |
$15,704,363 |
|
| Colombia | TB |
CCM |
Approved |
2B |
$5,390,584 |
$11,271,656 |
|
| Congo Rep. | HIV |
CCM |
Not approved |
3 |
€ 4,674,974 |
€ 9,978,943 |
|
| Congo DR | HIV |
CCM |
Not approved |
3 |
$111,533,674 |
$295,297,357 |
|
| Congo DR | Malaria |
CCM |
Approved |
2 |
$73,922,870 |
$185,122,386 |
|
| Cote d'Ivoire | HIV (DP + HSS part) |
CCM |
Not approved |
3 |
€ 57,632,004 |
€ 133,432,755 |
|
| Djibouti | TB |
CCM |
Approved |
2 |
€ 2,461,552 |
€ 6,080,117 |
|
| Dominican Rep. | HIV MARPs |
CCM |
Not approved |
4 |
$4,950,940 |
$12,496,996 |
|
| Eritrea * | HIV (DP + HSS part) |
CCM |
Approved |
2 |
$20,818,140 |
$59,897,311 |
|
| Eritrea * ** | TB |
CCM |
Approved |
2B |
$7,316,801 |
$22,815,431 |
|
| Ethiopia | HIV |
CCM |
Not approved |
3 |
$88,149,150 |
$176,458,326 |
|
| Ethiopia | Malaria (DP + HSS part) |
CCM |
Not approved |
3 |
$97,848,890 |
$245,989,480 |
|
| Ethiopia | TB |
CCM |
Not approved |
3 |
$21,107,334 |
$82,169,387 |
|
| Georgia | HIV MARPs |
CCM |
Approved |
2 |
€ 3,105,210 |
€ 8,860,077 |
|
| Georgia | TB |
CCM |
Approved |
2 |
€ 7,695,603 |
€ 21,727,729 |
|
| Ghana | HIV (DP + HSS part) |
CCM |
Not approved |
4 |
$499,428,723 |
$1,420,138,447 |
|
| Ghana * | TB |
CCM |
Approved |
2B |
$31,897,744 |
$77,418,445 |
|
| Guinea | HIV (DP + HSS part) |
CCM |
Approved |
2B |
$20,877,516 |
$56,875,437 |
|
| Guinea | Malaria |
CCM |
Approved |
2B |
$32,046,938 |
$46,625,648 |
|
| Guinea Bissau | HIV (DP + HSS part) |
CCM |
Not approved |
3 |
€ 26,167,631 |
€ 63,815,647 |
|
| Guyana | TB |
CCM |
Not approved |
4 |
$486,607 |
$1,050,801 |
|
| Honduras | TB |
CCM |
Approved |
2B |
$6,030,951 |
$12,402,425 |
|
| India | HIV |
CCM |
Not approved |
3 |
$21,412,956 |
$61,404,090 |
|
| Indonesia | TB (DP + HSS part) |
CCM |
Approved |
2 |
$47,727,271 |
$157,544,680 |
|
| Iran | Malaria |
CCM |
Approved |
2 |
$9,363,548 |
$19,578,464 |
|
| Jordan | TB |
CCM |
Approved |
2 |
$2,078,829 |
$4,666,284 |
|
| Kazakhstan | HIV MARPs |
CCM |
Approved |
2 |
$2,404,755 |
$12,449,062 |
|
| Kenya | HIV |
CCM |
Approved |
2B |
$93,376,285 |
$345,103,871 |
|
| Kenya | Malaria |
CCM |
Approved |
2 |
$49,979,579 |
$138,370,324 |
|
| Kyrgyz Rep. | HIV |
CCM |
Approved |
2 |
$11,207,840 |
$41,480,486 |
|
| Kyrgyz Rep. | TB |
CCM |
Not approved |
3 |
$3,842,777 |
$5,659,777 |
|
| Lao PDR | TB (HSS part) |
CCM |
Not approved |
n/a |
$8,155,754 |
$17,158,018 |
|
| Lao PDR ** | TB (DP) |
CCM |
Approved |
2 |
$3,255,999 |
$12,887,910 |
|
| Lesotho | HIV |
CCM |
Not approved |
3 |
$29,594,699 |
$65,273,286 |
|
| Liberia | Malaria (DP + HSS part) |
CCM |
Approved |
2 |
$28,698,063 |
$68,892,692 |
|
| Liberia | TB |
CCM |
Approved |
2B |
$2,862,226 |
$16,061,899 |
|
| Macedonia | HIV MARPs |
CCM |
Approved |
1 |
€ 2,825,259 |
€ 9,407,934 |
|
| Macedonia | TB |
CCM |
Approved |
2 |
€ 2,901,528 |
€ 6,112,713 |
|
| Madagascar | HIV (DP + HSS part) |
CCM |
Not approved |
3 |
$46,050,649 |
$110,739,971 |
|
| Malawi | HIV |
CCM |
Not approved |
3 |
$164,254,176 |
$561,450,164 |
|
| Malaysia | HIV MARPs |
CCM |
Approved |
2B |
$4,672,630 |
$12,405,288 |
|
| Maldives | HIV MARPs |
CCM |
Not approved |
3 |
$2,880,814 |
$8,044,746 |
|
| Mali | Malaria |
CCM |
Approved |
2B |
€ 24,827,735 |
€ 94,873,243 |
|
| Mali | TB |
CCM |
Approved |
2 |
€ 8,053,957 |
€ 13,773,341 |
|
| Mauritius | HIV MARPs |
CCM |
Not approved |
3 |
$2,870,148 |
$12,435,364 |
|
| Moldova | HIV MARPs |
CCM |
Not approved |
3 |
$3,849,298 |
$12,491,713 |
|
| Mongolia | HIV |
CCM |
Not approved |
4 |
$2,218,185 |
$7,248,739 |
|
| Mongolia ** | TB (DP + HSS part) |
CCM |
Approved |
2 |
$3,696,354 |
$9,052,049 |
|
| Morocco | HIV |
CCM |
Approved |
2 |
$14,672,516 |
$43,597,649 |
|
| Morocco | TB |
CCM |
Approved |
2 |
$5,014,439 |
$10,795,334 |
|
| Mozambique | HIV |
CCM |
Not approved |
3 |
$54,163,105 |
$131,214,912 |
|
| Mozambique | TB |
CCM |
Not approved |
3 |
$25,407,092 |
$69,822,783 |
|
| Namibia | HIV |
CCM |
Not approved |
4 |
$15,248,614 |
$44,292,453 |
|
| Namibia | TB |
CCM |
Approved |
2 |
$12,524,672 |
$32,994,241 |
|
| Nepal | HIV |
CCM |
Approved |
2 |
$16,150,553 |
$57,273,249 |
|
| Nicaragua | TB |
CCM |
Not approved |
3 |
$4,106,578 |
$8,247,665 |
|
| Niger | HIV |
CCM |
Not approved |
3 |
€ 30,335,989 |
€ 73,945,907 |
|
| Niger | Malaria |
CCM |
Not approved |
3 |
€ 72,627,052 |
€ 130,641,962 |
|
| Niger | TB (DP + HSS part) |
CCM |
Approved |
2B |
€ 19,035,383 |
€ 42,226,096 |
|
| Nigeria | HIV (DP + HSS part) |
CCM |
Not approved |
4 |
$97,491,288 |
$383,708,645 |
|
| Pakistan * | Malaria (DP) |
CCM |
Approved |
2B |
$23,395,667 |
$51,516,709 |
|
| Pakistan | Malaria (HSS part) |
CCM |
Not approved |
n/a |
$15,199,740 |
$21,594,900 |
|
| Panama | HIV MARPs |
CCM |
Approved |
2 |
$4,202,744 |
$10,273,513 |
|
| Papua NG * | HIV (DP + HSS part) |
CCM |
Approved |
2 |
$23,419,727 |
$46,697,052 |
|
| Peru | HIV MARPs |
CCM |
Approved |
2 |
$4,999,999 |
$12,499,997 |
|
| Peru | Malaria |
CCM |
Not approved |
3 |
$2,835,863 |
$7,741,937 |
|
| Peru | TB |
CCM |
Not approved |
3 |
$15,481,203 |
$29,837,075 |
|
| Russian Fed. | TB |
CCM |
Approved |
2B |
$63,472,958 |
$126,926,245 |
|
| Russian Fed. | TB | Sub-CCM | Not approved |
4 |
€ 20,170,145 |
€ 36,360,264 |
|
| Sao Tome & P. | HIV |
CCM |
Approved |
2 |
$1,279,852 |
$2,476,713 |
|
| Senegal | Malaria |
CCM |
Approved |
2 |
€ 21,650,781 |
€ 62,865,723 |
|
| Senegal * ** | TB |
CCM |
Approved |
2 |
€ 6,335,035 |
€ 17,460,725 |
|
| Sierra Leone | Malaria |
CCM |
Approved |
2 |
$23,255,609 |
$62,649,856 |
|
| Sierra Leone | TB (DP + HSS part) |
CCM |
Not approved |
3 |
$34,333,373 |
$77,234,629 |
|
| Somalia | Malaria (DP + HSS part) | Non-CCM | Approved |
2 |
$39,333,002 |
$84,550,325 |
|
| Somalia * ** | TB | Non-CCM | Approved |
2B |
$14,213,393 |
$58,380,928 |
|
| South Africa | HIV |
CCM |
Approved |
2 |
$128,481,275 |
$302,717,719 |
|
| Sri Lanka | TB (DP + HSS part) |
CCM |
Not approved |
3 |
$11,845,852 |
$25,088,859 |
|
| Sudan North | HIV |
CCM |
Approved |
2 |
$21,944,538 |
$61,919,606 |
|
| Sudan North | Malaria |
CCM |
Approved |
2B |
$61,256,082 |
$182,841,841 |
|
| Sudan South | HIV | Sub-CCM | Not approved |
4 |
$65,528,320 |
$135,697,425 |
|
| Sudan South | Malaria | Sub-CCM | Approved |
2 |
$26,486,653 |
$98,618,453 |
|
| Sudan South | TB | Sub-CCM | Not approved |
3 |
$16,374,061 |
$50,114,047 |
|
| Swaziland | HIV |
CCM |
Not approved |
3 |
$34,723,593 |
$89,609,304 |
|
| Swaziland ** | TB |
CCM |
Approved |
2 |
$11,202,195 |
$39,004,228 |
|
| Syria * | HIV MARPs |
CCM |
Approved |
2B |
$1,723,169 |
$3,396,722 |
|
| Tajikistan | HIV |
CCM |
Not approved |
3 |
$20,521,257 |
$64,745,498 |
|
| Tajikistan | TB |
CCM |
Not approved |
3 |
$49,913,253 |
$115,418,678 |
|
| Tanzania | HIV |
CCM |
Not approved |
3 |
$50,880,157 |
$113,178,230 |
|
| Tanzania | TB |
CCM |
Not approved |
3 |
$33,201,781 |
$68,786,103 |
|
| Thailand | HIV |
CCM |
Approved |
2 |
$15,398,249 |
$42,088,572 |
|
| Thailand * | Malaria |
CCM |
Approved |
2B |
$32,500,432 |
$78,378,690 |
|
| Thailand | TB |
CCM |
Approved |
2 |
$12,344,773 |
$31,716,829 |
|
| Timor-Leste | HIV |
CCM |
Approved |
1 |
$6,798,682 |
$14,254,688 |
|
| Timor-Leste * | Malaria |
CCM |
Approved |
2B |
$7,170,680 |
$22,349,915 |
|
| Timor-Leste | TB |
CCM |
Not approved |
3 |
$2,706,769 |
$9,661,901 |
|
| Togo | HIV |
CCM |
Not approved |
3 |
€ 6,280,885 |
€ 16,083,684 |
|
| Tunisia | HIV MARPs |
CCM |
Not approved |
3 |
$4,144,950 |
$12,499,365 |
|
| Uganda | HIV (DP) |
CCM |
Not approved |
n/a |
$55,834,292 |
$217,300,859 |
|
| Uganda | HIV (HSS part) |
CCM |
Approved |
2 |
$17,917,965 |
$25,251,193 |
|
| Uganda | Malaria |
CCM |
Approved |
2 |
$53,167,057 |
$155,963,673 |
|
| Uganda | TB |
CCM |
Approved |
2 |
$10,391,585 |
$24,757,129 |
|
| Ukraine | HIV |
CCM |
Approved |
2 |
$95,842,099 |
$305,535,421 |
|
| Uruguay | HIV MARPs |
CCM |
Approved |
2 |
$3,953,375 |
$9,572,417 |
|
| Uzbekistan | HIV |
CCM |
Approved |
2 |
$9,519,645 |
$14,828,347 |
|
| Vietnam | HIV (DP) |
CCM |
Not approved |
n/a |
$45,071,739 |
$188,864,423 |
|
| Vietnam | HIV (HSS part) |
CCM |
Approved |
2B |
$42,102,165 |
$86,636,150 |
|
| Yemen | HIV (DP + HSS part) |
CCM |
Not approved |
3 |
$14,565,766 |
$32,312,943 |
|
| Zambia * | HIV |
CCM |
Approved |
2 |
$102,851,986 |
$259,216,608 |
|
| Zanzibar (Tanz.) | TB |
CCM |
Approved |
2 |
$2,633,434 |
$5,912,925 |
|
| Zimbabwe | HIV (DP + HSS part) |
CCM |
Not approved |
3 |
$118,402,303 |
$342,054,472 |
|
| Zimbabwe | Malaria |
CCM |
Approved |
2 |
$14,550,666 |
$24,960,569 |
|
| Zimbabwe | TB |
CCM |
Not approved |
3 |
$12,193,205 |
$25,507,117 |
|
|
Total – 135 country-based proposals |
|||||||
Table 10: Round 10 results for regional applicants
Note: For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.|
Applicant |
Disease component |
Applicant type |
Decision |
Cate-gory |
Cost |
|
|
Years 1-2 |
Years 1-5 |
|||||
| AMREF (Re Burundi, Ethiopia, Kenya, Tanzania, Uganda) | TB |
RO |
Not approved |
4 |
$29,868,200 |
$63,996,437 |
| APN+ (Re Bangladesh, Indonesia, Lao PDR, Nepal, Pakistan, Philippines, Viet Nam) * | HIV |
RO |
Approved |
2 |
$1,200,000 |
$3,000,000 |
| ASICAL (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay) | HIV MARPs |
RO |
Not approved |
3 |
$4,827,281 |
$11,149,346 |
| CONGA (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama) | HIV MARPs |
RO |
Not approved |
4 |
$4,506,212 |
$12,451,594 |
| ECSA (Re Zambia, Zimbabwe) | TB |
RO |
Not approved |
3 |
$3,322,054 |
$14,593,861 |
| GLIA (Re Burundi, Congo DR, Kenya, Rwanda, Tanzania, Uganda) | HIV MARPs |
RO |
Not approved |
4 |
$4,873,647 |
$12,499,735 |
| HIVOS-SA (Re Lesotho, Mauritius, Namibia, South Africa, Swaziland) | HIV |
RO |
Not approved |
4 |
$12,130,614 |
$36,066,771 |
| ISEAN-HIVOS (Re Indonesia, Malaysia, Philippines, Timor-Leste) | HIV MARPs |
RO |
Approved |
2B |
$4,767,802 |
$12,473,395 |
| MENAHRA (Re Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, West Bank and Gaza, Pakistan, Syria, Tunisia) * | HIV MARPs |
RO |
Approved |
2B |
$3,209,492 |
$8,352,698 |
| Meso (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama) | HIV |
RCM |
Not approved |
3 |
$7,868,536 |
$23,214,775 |
| MOZIZA (Re Mozambique, South Africa, Zimbabwe) | Malaria |
RCM |
Not approved |
4 |
$12,322,727 |
$28,043,158 |
| OECS (Re Antigua and Barbuda, Dominica, Grenada, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and Grenadines) | HIV |
RCM |
Not approved |
3 |
$3,112,877 |
$9,059,745 |
| REDCA+ (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama) ** | HIV |
RO |
Approved |
2 |
$2,366,057 |
$9,229,855 |
| REDLACTRANS (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay) | HIV MARPs |
RO |
Not approved |
3 |
$4,994,209 |
$12,500,000 |
| REDTRASEX (Re Argentina, Bolivia, Brazil, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay) | HIV MARPs |
RO |
Approved |
2 |
$4,328,974 |
$12,496,279 |
|
Total – 15 regional proposals |
||||||
RO = Regional organisation RCM = Regional coordinating mechanism
* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal. ** This is a consolidated proposal. The TRP-recommended funding has been reduced to remove amounts included in the proposal for existing, already funded programmes.
